LONDON, UK: Belluscura plc (AIM: BELL), a leading medical device developer focused on lightweight and portable oxygen enrichment technology, announced that early results on the two-month-old direct to consumer program have exceeded the Board’s initial expectations. The company has introduced a three-prong direct sales, leasing and short-term rental program for its established X-PLOR® device that…
All posts tagged Belluscura plc
Belluscura inks exclusive partnership for oxygen enrichment devices
LONDON, UK: Belluscura plc (AIM: BELL), a leading innovator in medical devices specializing in lightweight and portable oxygen enrichment technology, has forged a significant Exclusive License, Marketing, and Distribution Agreement with global manufacturing partner InnoMax Medical Technology Ltd (“InnoMax”). InnoMax, headquartered in Shenzhen, China, has secured the exclusive rights to manufacture and distribute Belluscura’s acclaimed…
Belluscura PLC signs first US distribution agreement
LONDON, U.K: Belluscura plc, a leading medical device developer focused on lightweight and portable oxygen enrichment technology, announces that, as anticipated, it has signed its first US distribution agreement for its X-PLO2R portable oxygen concentrator (POC) portfolio. This is the first stage in establishing US-wide distribution coverage as part of the Group’s commercialisation strategy. The distributor, located on the…
Belluscura plc announces intention to float on AIM of London Stock Exchange
LONDON: Belluscura plc, a leading medical device developer focused on lightweight and portable oxygen enrichment technology, announced its intention to list entire issued and to be issued ordinary share capital of the Company to the AIM market of the London Stock Exchange. Belluscura’s first product, the X-PLO2 RTM, is a lightweight FDA cleared portable oxygen…